BG108435A - Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride - Google Patents
Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochlorideInfo
- Publication number
- BG108435A BG108435A BG108435A BG10843503A BG108435A BG 108435 A BG108435 A BG 108435A BG 108435 A BG108435 A BG 108435A BG 10843503 A BG10843503 A BG 10843503A BG 108435 A BG108435 A BG 108435A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alpha
- hydrochloride
- hydroxybutyl
- piperidinyl
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA2001 | 2001-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG108435A true BG108435A (en) | 2004-12-30 |
Family
ID=34566868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG108435A BG108435A (en) | 2001-06-18 | 2003-12-11 | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP2261209A1 (cs) |
| JP (2) | JP2005507374A (cs) |
| KR (1) | KR20040015734A (cs) |
| CN (1) | CN100390145C (cs) |
| AU (1) | AU2001278094B2 (cs) |
| BG (1) | BG108435A (cs) |
| BR (1) | BR0117054A (cs) |
| CA (2) | CA2450858C (cs) |
| CO (1) | CO5540340A2 (cs) |
| CZ (1) | CZ20033358A3 (cs) |
| EE (1) | EE200400010A (cs) |
| HU (1) | HUP0401546A2 (cs) |
| IL (2) | IL159266A0 (cs) |
| MX (1) | MXPA03011728A (cs) |
| NZ (1) | NZ530118A (cs) |
| PL (1) | PL367632A1 (cs) |
| RU (1) | RU2269516C2 (cs) |
| SK (1) | SK15372003A3 (cs) |
| WO (1) | WO2002102777A2 (cs) |
| ZA (1) | ZA200309557B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL366576A1 (en) * | 2001-04-09 | 2005-02-07 | Teva Pharmaceutical Industries Ltd. | Polymorphs of fexofenadine hydrochloride |
| US20040044038A1 (en) | 2002-06-10 | 2004-03-04 | Barnaba Krochmal | Polymorphic form XVI of fexofenadine hydrochloride |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| EP1628959A2 (en) * | 2004-04-26 | 2006-03-01 | Teva Pharmaceutical Industries Ltd | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
| ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
| JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
| WO2007007347A1 (en) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Industrial process of fexofenadine hydrochloride with controlled side products |
| EP2105134A1 (en) | 2008-03-24 | 2009-09-30 | Ranbaxy Laboratories Limited | Stable amorphous fexofenadine hydrochloride |
| CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| JPH10500134A (ja) * | 1994-05-18 | 1998-01-06 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 抗ヒスタミン性ピペリジン誘導体の無水および水和形態、それらの多形態および擬似形態の製造方法 |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| IN191492B (cs) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/en active IP Right Grant
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Application Discontinuation
- 2001-07-31 CA CA002450858A patent/CA2450858C/en not_active Expired - Fee Related
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 CA CA002646802A patent/CA2646802A1/en not_active Abandoned
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 EP EP10010066A patent/EP2261209A1/en not_active Withdrawn
- 2001-07-31 EP EP01956057A patent/EP1399422A2/en not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
-
2003
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20033358A3 (en) | 2004-04-14 |
| WO2002102777A8 (en) | 2003-10-30 |
| CN1518540A (zh) | 2004-08-04 |
| BR0117054A (pt) | 2004-07-27 |
| CA2450858C (en) | 2009-04-07 |
| JP2008094848A (ja) | 2008-04-24 |
| SK15372003A3 (sk) | 2004-08-03 |
| EP2261209A1 (en) | 2010-12-15 |
| AU2001278094B2 (en) | 2006-01-12 |
| RU2004101045A (ru) | 2005-06-27 |
| RU2269516C2 (ru) | 2006-02-10 |
| IL159266A0 (en) | 2004-06-01 |
| CA2450858A1 (en) | 2002-12-27 |
| WO2002102777A3 (en) | 2003-02-27 |
| WO2002102777A2 (en) | 2002-12-27 |
| MXPA03011728A (es) | 2004-07-08 |
| IL159266A (en) | 2010-11-30 |
| CN100390145C (zh) | 2008-05-28 |
| PL367632A1 (en) | 2005-03-07 |
| NZ530118A (en) | 2007-05-31 |
| EE200400010A (et) | 2004-02-16 |
| EP1399422A2 (en) | 2004-03-24 |
| JP2005507374A (ja) | 2005-03-17 |
| KR20040015734A (ko) | 2004-02-19 |
| CA2646802A1 (en) | 2002-12-27 |
| HUP0401546A2 (hu) | 2004-12-28 |
| ZA200309557B (en) | 2004-09-14 |
| CO5540340A2 (es) | 2005-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG108435A (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
| DK153709B (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanolderivater | |
| SK145894A3 (en) | Vinegar acid derivatives, method of their production, pharmaceutical agents on their base and their using | |
| NO162819B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyrederivater. | |
| JP2009533369A5 (cs) | ||
| WO2007072087A3 (en) | Novel process for production of highly pure polymorph (i) donepezil hydrochloride | |
| AU2005272389A1 (en) | Novel cyclic aminobenzoic acid derivative | |
| CA2584833A1 (en) | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines | |
| IL180192A (en) | The result of arylamide, its salt and the antifungals that contain them | |
| US5166148A (en) | 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity | |
| JP5673729B2 (ja) | ４−置換又は非置換テトラヒドロピラン−４−カルボン酸化合物又はそのエステル化合物の製法 | |
| JP2010536713A5 (cs) | ||
| CA2429563C (en) | Process for the preparation of donepezil | |
| NO20082474L (no) | Fremgangsmate for fremstilling av en leukotrienantagonist og intermediater derav | |
| WO2007144391A1 (en) | Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation | |
| JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
| TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
| DK1489080T3 (da) | Fremgangsmåde til frembringelse af cilostazol | |
| PL353977A1 (en) | Method of obtaining 4-[1-hydroxy-4-[4-(hydroxydiphenyldimethyl)-1-piperidinylbutyl]-alpha,alpha-dimethylbenzene acetic acid | |
| AU2008288430A1 (en) | Novel preparation process | |
| ZA200007034B (en) | Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof. | |
| WO2006013049A3 (en) | Benzyloxy derivatives as maob inhibitors | |
| WO2005076749A3 (en) | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine | |
| WO2009084030A3 (en) | Improved process for the preparation of (1-benzyl-4-(5,6,- dimethoxyind anone-2-yl)methylpiperidine) hydrochloride-form iii | |
| NO20083709L (no) | Nye krystallinske forbindelser |